Investors

Press Releases

Jun 29, 2016 • 9:32 AM EDT

Endonovo Therapeutics Files Continuation Patent for Producing Adult Stem Cell Secretome

Jun 23, 2016 • 5:02 AM EDT

Endonovo Therapeutics Awarded Preliminary Injunction Against Kodiak Capital et al

Jun 15, 2016 • 9:07 AM EDT

Endonovo Therapeutics Provides Update on Variable Convertible Notes

May 5, 2016 • 2:45 PM EDT

Endonovo Therapeutics to Present at the 2016 Marcum Microcap Conference in New York

Apr 13, 2016 • 8:34 AM EDT

Endonovo Therapeutics to Present at the SeeThruEquity 5th Annual Microcap Investor Conference in New York

Mar 30, 2016 • 3:12 PM EDT

Endonovo Therapeutics Receives USPTO Notice of Allowance for Patent Covering Production of Biomolecules From Adult Stem Cells

Mar 14, 2016 • 3:09 PM EDT

Endonovo Therapeutics Provides Corporate Update and 2016 Outlook

Feb 11, 2016 • 7:30 AM EST

Endonovo Therapeutics Retains Holland & Knight to File for Orphan Drug Designation

Dec 11, 2015 • 10:00 AM EST

Endonovo Therapeutics Buys Back Convertible Note From Lender Avoiding Any Immediate Dilution

Nov 3, 2015 • 7:00 AM EST

Endonovo Therapeutics Developing Next-Generation Cell Therapy for Acute and Chronic Graft-Versus-Host Disease Using Cell-Enhancing Cytotronics Platform

<< Previous
1...
3
4
5
6
7
8
9
10
11
12
Next >>

Show All